(AGENPARL) – SILVER SPRING lun 17 aprile 2023 The purpose of this public workshop is to discuss topics relevant to the development of endpoints for rare diseases.
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/fda-cder-and-cber-duke-margolis-center-health-policy-rare-disease-endpoint-advancement-pilot-program